The Immunology of Macrophage Activation Syndrome
Synonymous with secondary hemophagocytic lymphohistiocytosis, macrophage activation syndrome (MAS) is a term used by rheumatologists to describe a potentially life-threatening complication of systemic inflammatory disorders, most commonly systemic juvenile idiopathic arthritis (sJIA) and systemic lu...
Main Authors: | Courtney B. Crayne, Sabrin Albeituni, Kim E. Nichols, Randy Q. Cron |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00119/full |
Similar Items
-
IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome
by: Etienne Dufranc, et al.
Published: (2020-04-01) -
Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis
by: Camille Keenan, et al.
Published: (2021-02-01) -
Protection from inflammatory organ damage in a murine model of hemophagocytic lymphohistiocytosis using treatment with IL-18 binding protein
by: Laura eChiossone, et al.
Published: (2012-08-01) -
A Rare STXBP2 Mutation in Severe COVID-19 and Secondary Cytokine Storm Syndrome
by: Daniel D. Reiff, et al.
Published: (2022-01-01) -
Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids
by: Yi Miao, et al.
Published: (2020-06-01)